BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14586381)

  • 21. New (still proposed) rules for sunscreen. UVA testing and ranking may be the most important change.
    Harv Health Lett; 2010 Jun; 35(8):6. PubMed ID: 20700956
    [No Abstract]   [Full Text] [Related]  

  • 22. Over-the-counter medication labels: Problems and needs of the elderly population.
    Pawaskar MD; Sansgiry SS
    J Am Geriatr Soc; 2006 Dec; 54(12):1955-6. PubMed ID: 17198515
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial: Safe and sane use of OTC's.
    Tice LF
    Am J Pharm Sci Support Public Health; 1973; 145(6):187-8. PubMed ID: 4768815
    [No Abstract]   [Full Text] [Related]  

  • 24. Time for evidence-based labelling of over-the-counter medicines.
    MacLennan AH; Sturdee DW
    Climacteric; 2007 Jun; 10(3):179-80. PubMed ID: 17487644
    [No Abstract]   [Full Text] [Related]  

  • 25. Consumer involvement: effects on information processing from over-the-counter medication labels.
    Sansgiry SS; Cady PS; Sansgiry S
    Health Mark Q; 2001; 19(1):61-78. PubMed ID: 11727293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Instructions provided by manufacturers for proper use of nonprescription ophthalmic drops.
    Lisi DM; Fazio A
    Am J Hosp Pharm; 1991 May; 48(5):987-8. PubMed ID: 1853881
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of need for cognition and principal display panel factors on over-the-counter drug facts label comprehension.
    Catlin JR; Pechmann C; Brass EP
    Health Commun; 2012; 27(3):264-72. PubMed ID: 21899401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonprescription drugs: an overview.
    Hodes B
    Int J Health Serv; 1974; 4(1):125-30. PubMed ID: 4829892
    [No Abstract]   [Full Text] [Related]  

  • 29. Safe & sound. Interview by Helena Gail Rubinstein.
    Woodcock J
    AHIP Cover; 2009; 50(2):38-43. PubMed ID: 19385317
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial: Quantitative formula disclosure.
    Feldman EG
    J Pharm Sci; 1974 Dec; 63(12):1. PubMed ID: 4449011
    [No Abstract]   [Full Text] [Related]  

  • 31. Lack of pregnancy warnings on over-the-counter dermatologic products containing potentially harmful hydroquinone.
    Bio LL; Cies JJ
    J Perinatol; 2017 Jul; 37(7):778-781. PubMed ID: 28358386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug labeling; sodium labeling for over-the-counter drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(228):69278-80. PubMed ID: 15570675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Nov; 72(230):67639-40. PubMed ID: 18064767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Mar; 69(57):13725-35. PubMed ID: 15040351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Panel reports on sleep-aids.
    Hecht A
    FDA Consum; 1976 Feb; 10(1):10-3. PubMed ID: 829089
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of warning placement on the information processing of college students reading an OTC drug facts panel.
    Bhansali AH; Sangani DS; Mhatre SK; Sansgiry SS
    J Am Coll Health; 2018; 66(4):237-245. PubMed ID: 29405851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(195):58974-7. PubMed ID: 16217879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The instrumental role of product information: a study of warning labels for non-prescription drugs.
    Discenza R; Ferguson JM
    Health Mark Q; 1992; 10(1-2):155-68. PubMed ID: 10124787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What you need to know: over the counter slimming products--their rationality and legality.
    Candlish JK
    Singapore Med J; 1999 Aug; 40(8):550-2. PubMed ID: 10572500
    [No Abstract]   [Full Text] [Related]  

  • 40. Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(250):75414-8. PubMed ID: 14986677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.